Login / Signup

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders.

Nicolò De GennaroLucia DiellaLaura MonnoGioacchino AngaranoMichele MilellaAnnalisa Saracino
Published in: BMC infectious diseases (2020)
The study confirms effectiveness and safety of DAA-based treatment also in this special population, even if a careful evaluation of history and drug-drug interactions is warranted.
Keyphrases